Chemoinformaics analysis of 1-(4-Hydroxyphenyl)ethane-1,2-diol
| Molecular Weight | 154.165 | nRot | 2 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 12 |
| Exact Molecular Weight | 154.063 | nRing | 1 |
| Solubility: LogS | -5.226 | nHRing | 0 |
| Solubility: LogP | 5.813 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 22.4339 |
| nHD | 3 | BPOL | 10.0321 |
| QED | 0.485 |
| Synth | 3.887 |
| Natural Product Likeliness | 3.043 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.452 |
| MDCK | 0.0000145 |
| BBB | 0.759 |
| PPB | 0.945451 |
| VDSS | 2.666 |
| FU | 0.0530155 |
| CYP1A2-inh | 0.789 |
| CYP1A2-sub | 0.356 |
| CYP2c19-inh | 0.475 |
| CYP2c19-sub | 0.409 |
| CYP2c9-inh | 0.367 |
| CYP2c9-sub | 0.883 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.853 |
| CYP3a4-inh | 0.302 |
| CYP3a4-sub | 0.193 |
| CL | 6.651 |
| T12 | 0.123 |
| hERG | 0.008 |
| Ames | 0.004 |
| ROA | 0.006 |
| SkinSen | 0.816 |
| Carcinogencity | 0.889 |
| EI | 0.963 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.888992 |